Plain-English translation of NCT07081360 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Pancreas Cancer research guide โPhase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new treatment approach for pancreatic cancer and related cancers of the bile duct. Half of participants will receive chemotherapy (mFOLFIRINOX) before surgery, while the other half will have surgery first and then receive chemotherapy afterward. Researchers want to see whether treating with the medication before surgery helps patients live longer and have better outcomes overall.
Pancreatic cancer is a serious disease with poor survival rates even after surgery. This trial exists because doctors believe that giving this medication before surgery might eliminate hidden cancer cells throughout the body and help surgeons remove the tumor more completely, which could improve long-term survival.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will be randomly assigned to one of two groups. One group receives chemotherapy treatment over several months before undergoing pancreatic surgery, while the other group has surgery first and then receives chemotherapy afterward. You will have regular clinic visits for monitoring, blood tests, imaging scans, and follow-up appointments to track your health and cancer status over time.
AI-generated summary from trial data ยท Oct 2, 2026 ยท Not medical advice
Egypt